Literature DB >> 19464431

Hsp90 inhibitors, GA and 17AAG, lead to ER stress-induced apoptosis in rat histiocytoma.

Aftab Taiyab1, Amere S Sreedhar, Ch Mohan Rao.   

Abstract

Heat shock protein 90 (Hsp90) is a major molecular chaperone that plays an essential role in the maintenance of several signaling molecules, most of which are oncogenic kinases. Hsp90 inhibition by specific inhibitors leads to destabilization and loss of activity of such proteins, thereby leading to inhibition of multiple signaling cascades. Due to this, Hsp90 has emerged as an important target for the treatment of cancer. Inhibition of Hsp90 has been reported to induce apoptosis in certain cancer cell types. However, the molecular details of induction of apoptosis upon Hsp90 inhibition are not understood. We have investigated the effect of Hsp90 inhibition on a non-adherent rat histiocytoma cell line, BC-8, using geldanamycin and 17-Allylamino-17-demethoxygeldanamycin. We show that Hsp90 inhibition induces ER stress, which leads to disruption of mitochondrial homeostasis, leading to apoptosis. Induction of ER stress leads to increased expression of ER chaperones, Grp78 and Grp94, cleavage of caspase-12 and increase in cytoplasmic calcium. We show that calcium and Bax are responsible for the decrease in mitochondrial membrane potential (Deltapsi(m)), thereby leading to the release of cytochrome c and activation of caspase-9. Moreover, calcium chelator and over-expression of Bcl-2 is able to confer protection against apoptosis upon Hsp90 inhibition. We conclude that inhibition of Hsp90 leads to ER stress-induced mitochondria-mediated apoptosis and that Bax and Ca(2+) play an important role in mitochondrial damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464431     DOI: 10.1016/j.bcp.2009.04.001

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  23 in total

Review 1.  Endoplasmic-reticulum calcium depletion and disease.

Authors:  Djalila Mekahli; Geert Bultynck; Jan B Parys; Humbert De Smedt; Ludwig Missiaen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

Review 2.  Congenital nephrogenic diabetes insipidus: the current state of affairs.

Authors:  Daniel Wesche; Peter M T Deen; Nine V A M Knoers
Journal:  Pediatr Nephrol       Date:  2012-03-17       Impact factor: 3.714

3.  Inhibition of gastric tumor growth by a novel Hsp90 inhibitor.

Authors:  Chunwan Lu; Di Liu; Jing Jin; Hemantkumar Deokar; Yi Zhang; John K Buolamwini; Xiaoming Yu; Chunhong Yan; Xiaoguang Chen
Journal:  Biochem Pharmacol       Date:  2013-02-13       Impact factor: 5.858

Review 4.  Unfolded Protein Response supports endothelial barrier function.

Authors:  Nektarios Barabutis
Journal:  Biochimie       Date:  2019-08-09       Impact factor: 4.079

5.  Cdc37/Hsp90 protein-mediated regulation of IRE1α protein activity in endoplasmic reticulum stress response and insulin synthesis in INS-1 cells.

Authors:  Asuka Ota; Yibin Wang
Journal:  J Biol Chem       Date:  2011-12-23       Impact factor: 5.157

6.  Maternal nutritional history modulates the hepatic IGF-IGFBP axis in adult male rat offspring.

Authors:  Timothy Smith; Deborah M Sloboda; Richard Saffery; Eric Joo; Mark H Vickers
Journal:  Endocrine       Date:  2013-08-21       Impact factor: 3.633

7.  Galactose-1 phosphate uridylyltransferase (GalT) gene: A novel positive regulator of the PI3K/Akt signaling pathway in mouse fibroblasts.

Authors:  Bijina Balakrishnan; Wyman Chen; Manshu Tang; Xiaoping Huang; Didem Demirbas Cakici; Anwer Siddiqi; Gerard Berry; Kent Lai
Journal:  Biochem Biophys Res Commun       Date:  2016-01-08       Impact factor: 3.575

8.  Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathway.

Authors:  Akira Wagatsuma; Yuzo Takayama; Takayuki Hoshino; Masataka Shiozuka; Shigeru Yamada; Ryoichi Matsuda; Kunihiko Mabuchi
Journal:  Mol Cell Biochem       Date:  2017-12-16       Impact factor: 3.396

9.  Inhibition of HSP90 overcomes melphalan resistance through downregulation of Src in multiple myeloma cells.

Authors:  Mitsuki Tabata; Masanobu Tsubaki; Tomoya Takeda; Keisuke Tateishi; Saho Maekawa; Katsumasa Tsurushima; Motohiro Imano; Takao Satou; Toshihiko Ishizaka; Shozo Nishida
Journal:  Clin Exp Med       Date:  2019-10-24       Impact factor: 3.984

10.  Molecular mechanism of cytotoxicity induced by Hsp90-targeted Antp-TPR hybrid peptide in glioblastoma cells.

Authors:  Tomohisa Horibe; Aya Torisawa; Masayuki Kohno; Koji Kawakami
Journal:  Mol Cancer       Date:  2012-08-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.